HomeToxicity-Related Discontinuation of Immunotherapy and Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with Immune-Based Combinations (ARON-1 Study)

Toxicity-Related Discontinuation of Immunotherapy and Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with Immune-Based Combinations (ARON-1 Study)